Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Zipfel

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
The Journal of Biological Chemistry|December 16, 2000
Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partnersR Pio, A Martinez, E J Unsworth, et al.
Clinical and Experimental Immunology|June 5, 2003
Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritisM A Friese, T Manuelian, S Junnikkala, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2003
CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian childrenNele Braun, Yeboah Marfo, Christiane Von Gärtner, et al.
Clinical and Experimental Immunology|April 26, 2006
The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native proteinM Oppermann, T Manuelian, M Józsi, et al.
Clinical and Experimental Immunology|August 10, 2000
Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)M A Friese, J Hellwage, T S Jokiranta, et al.
International Journal of Immunogenetics|February 3, 2012
Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic reviewD T Bradley, T W Bourke, D J Fairley, et al.
Kidney International|April 14, 2006
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)C Licht, S Heinen, M Józsi, et al.
Molecular Immunology|October 5, 2007
Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding proteinG Vogl, I Lesiak, D B Jensen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2012
Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumabD Noone, J Al-Matrafi, K Tinckam, et al.
Journal of Medical Genetics|November 22, 2005
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)M A Abrera-Abeleda, C Nishimura, J L H Smith, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
The Journal of Biological Chemistry|December 16, 2000
Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partnersR Pio, A Martinez, E J Unsworth, et al.
Clinical and Experimental Immunology|June 5, 2003
Release of endogenous anti-inflammatory complement regulators FHL-1 and factor H protects synovial fibroblasts during rheumatoid arthritisM A Friese, T Manuelian, S Junnikkala, et al.
Tropical Medicine & International Health : TM & IH|November 25, 2003
CTLA-4 positive T cells in contrast to procalcitonin plasma levels discriminate between severe and uncomplicated Plasmodium falciparum malaria in Ghanaian childrenNele Braun, Yeboah Marfo, Christiane Von Gärtner, et al.
Clinical and Experimental Immunology|April 26, 2006
The C-terminus of complement regulator Factor H mediates target recognition: evidence for a compact conformation of the native proteinM Oppermann, T Manuelian, M Józsi, et al.
Clinical and Experimental Immunology|August 10, 2000
Different regulation of factor H and FHL-1/reconectin by inflammatory mediators and expression of the two proteins in rheumatoid arthritis (RA)M A Friese, J Hellwage, T S Jokiranta, et al.
International Journal of Immunogenetics|February 3, 2012
Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic reviewD T Bradley, T W Bourke, D J Fairley, et al.
Kidney International|April 14, 2006
Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II)C Licht, S Heinen, M Józsi, et al.
Molecular Immunology|October 5, 2007
Immune evasion by acquisition of complement inhibitors: the mould Aspergillus binds both factor H and C4b binding proteinG Vogl, I Lesiak, D B Jensen, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 12, 2012
Antibody mediated rejection associated with complement factor h-related protein 3/1 deficiency successfully treated with eculizumabD Noone, J Al-Matrafi, K Tinckam, et al.
Journal of Medical Genetics|November 22, 2005
Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)M A Abrera-Abeleda, C Nishimura, J L H Smith, et al.
Pageof 10